Iran, Russia discussing joint production of Covid-19 vaccine: Report
The Russian Direct Investment Fund has said it is in talks with a number of countries about the possibility of producing the Russian 'Sputnik-V' vaccine abroad
 "Iran, Russia discussing joint production of Covid-19 vaccine: Report")
MOSCOW (Reuters) - Iran and Russia's sovereign wealth fund RDIF are discussing the joint production of a vaccine against COVID-19, Russian news agencies cited the Iranian ambassador to Moscow as saying on Friday.
"We are holding talks, I spoke with the head of RDIF Kirill Dmitriev, our officials have held several rounds of consultations and we announced that we will co-operate," Ambassador to Moscow Kazem Jalali was cited as saying.
Thus far, Russia has struck a manufacturing partnership deal with India, which is due to produce 300 million doses of the 'Sputnik-V' vaccine domestically. It is also discussing such partnerships with several other countries, including Brazil.
(Reporting by Anton Kolodyazhnyy; Writing by Polina Ivanova; Editing by Toby Chopra)
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)